Empresa Cell MedX Corp. Other OTC
Acciones
CMXC
US15115X1072
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58,8
%
| 0 | 60,6 % | 0 | 58,8 % | -55,85 % |
eBalance Devices
41,2
%
| 0 | 39,4 % | 0 | 41,2 % | -52,33 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -54,46 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24/11/14 |
George Adams
CHM | Chairman | 76 | 23/03/18 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/06/20 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/04/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/04/22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/06/20 |
George Adams
CHM | Chairman | 76 | 23/03/18 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24/11/14 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 297 236 373 | 60 447 694 ( 20,34 %) | 0 | 20,34 % |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,63 % | 50,93 mil M | |
-0,09 % | 42,12 mil M | |
+49,62 % | 42,05 mil M | |
-4,96 % | 29,18 mil M | |
+11,18 % | 26,02 mil M | |
-21,95 % | 18,9 mil M | |
+8,61 % | 13,21 mil M | |
+24,73 % | 12,17 mil M | |
+28,31 % | 12,16 mil M |